Drug-Resistant Tuberculosis : A Survival Guide for Clinicians. Third Edition.

Details

• Corporate Authors:
  Curry International Tuberculosis Center. ; California. Department of Public Health. Tuberculosis Control Branch. ; Centers for Disease Control and Prevention (U.S.)
• Description:
  Second printing. Correction made to Chapter 6, Pediatrics, Page 163, Pediatric Drug Dosing, Table 4, Pyrazinamide.
  
  Online update: June 7, 2016, October 25, 2016
  
  Suggested citation: Curry International Tuberculosis Center and California Department of Public Health, 2016: Drug-Resistant Tuberculosis: A Survival Guide for Clinicians, Third Edition [inclusive page numbers].
  
  CITC is a project of the University of California, San Francisco, funded by the Centers for Disease Control and Prevention (CDC). The development of the third edition of this Guide was funded through CDC Cooperative Agreement 1U52/PS004088-01. The views expressed in written materials or publications do not necessarily reflect the official policies of the Department of Health and Human Services, nor does the mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
  
  tb_sg3_book.pdf
  
  
• Subjects:
  Anti-Bacterial Agents Anti-Infective Agents Antimicrobial Stewardship Drug Resistance, Microbial Extensively Drug-Resistant Tuberculosis Tuberculosis, Multidrug-Resistant
• Document Type:
  Book
• Funding:
  CDC Cooperative Agreement 1U52/PS004088-0
• Pages in Document:
  xiv, 305 numbered pages
• Collection(s):
  Stephen B. Thacker CDC Library
• Main Document Checksum:
  urn:sha256:7c307001bc04739779d04ae6f481512df43037d70ae0147d32a1d70f0883187c
• Download URL:
  https://stacks.cdc.gov/view/cdc/154418/cdc_154418_DS1.pdf
• File Type:
  [PDF - 6.77 MB ]